From £7.99 per month
ShareProphets
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares

MINDING THE LSE’S BUSINESS

Join for as low as £7.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

Tom Winnifrith Bearcast: Pure unadulterated bull from the Zoetic fraud

By Tom Winnifrith | Tuesday 3 August 2021


Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.


While I was recording bearcast, Zoetic (ZOE) announced that since promising results in July on May 17 – by when it would already have done much of the audit work – it had discovered all about covid so would not now be releasing, what will be piss poor, results (for the year to March 31 2021) until this month. Good news travels fast, bad news is delayed. The real reason for the delay is explained in this podcast. I also cover discussions with the regulators on UK Oil & Gas (UKOG), Supply@ME Capital (SYME), the John Story episode and getting the shyster resigned from Escape Hunt (ESC). I speculate on what he did next. And there is a final appeal for Ian Westbrook. Do not let the loathsome pig Neill Ricketts win by default, please donate HERE

You must be a paid subscriber to listen to Bearcast
ShareProphets is reader-supported journalism

Join us for free and gain access to three articles per month

Or become a member starting at £6.99 per month for all articles, the Bearcast, and our seven year archive.


Filed under:



Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Market News

Complete Coverage

Recent Comments

That Was the Week that Was

 

AAU

Gold up Ariana down

Saturday »

AVCT

Cassava, A warning to Avacta Sharehoders 

Friday »

ALU

Alumasc Group – a growth Buy

 

VCP

Victoria - The roll up unravels

 

HEMO

Hemogenyx is a short – target 0p

 

ECR

ECR, the timing is unfortunate

 

APH

Alliance Pharma – a recovery Buy?

Time left: 17:54:58